This is a study to evaluate the long-term safety of methylphenidate hydrochloride (Concerta) extended-release tablets at five dose levels (36 mg, 54 mg, 72 mg, 90 mg, and 108 mg per day) in adults with attention-deficit/hyperactivity disorder (ADHD). This national study is currently recruiting patients.
Read moreA couple of months ago, after I was diagnosed with diabetes, my psychiatrist and I had a talk about my medications. Throughout the time I'd... Read more »
Full Question:My 15 year old daughter has had a migraine since her concussion on Dec. 13, 2006. She did have a past history with migraines... Read more »
For those of us with frequent headaches or Migraine attacks, preventive medications are often a good option. Amazingly, the medications used for... Read more »
Erectile dysfunction, sometimes called "impotence," is the repeated inability to get or keep an erection firm enough for sexual intercourse. The word... Read more »